Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For CCCS
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 10.37 2.53 2.29
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 21.51 13.57 11.17
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.35 2.98 2.88
Cash 0.96 0.32 0.32
Capex -36.57 -0.03 -0.02
Free Cash Flow -45.54 0.07 0.12
Revenue 2.66 0.38 0.37
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -2.20 0.74 0.76
Operating Margin -59.49 0.03 0.08
ROA -93.04 < 0.005 < 0.005
ROE -93.11 < 0.005 0.01
ROIC -93.74 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of CCCS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of CCCS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of CCCS is permitted for members.